Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Chiodi

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Physical Review Letters|November 13, 2009
Evidence for two time scales in long SNS junctionsF Chiodi, M Aprili, B Reulet
Drug and Alcohol Dependence|May 1, 1988
Guillain-Barré syndrome in chronic alcoholismL Pastena, F Chiodi, A Ceddia
AIDS Research and Human Retroviruses|August 10, 1996
Conference summary: pathogenic mechanisms of HIV type 1-associated neurological syndromesF Chiodi, S Britton, I Elovaara
Journal of Internal Medicine|June 30, 2007
Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccinesJ Albert, F Chiodi, E M Fenyö
AIDS Research and Human Retroviruses|July 1, 1996
Lack of correlation between V3 amino acid sequence and syncytium-inducing capacity of some HIV type 1 isolatesF Sabri, F Chiodi, E M Fenyö
International Immunology|April 9, 1998
A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sitesB Fadeel, J Lindberg, A Achour, et al.
Virology|August 1, 1991
Brain-derived cells can be infected with HIV isolates derived from both blood and brainB Keys, J Albert, J Kövamees, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1994
Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2E Björling, F Chiodi, G Utter, et al.
Cell Death & Disease|March 18, 2011
Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infectionM Krzyzowska, A Shestakov, K Eriksson, et al.
Chemical Immunology|January 1, 1993
Antigenic and immunogenic sites of HIV-2 glycoproteinsF Chiodi, E Björling, A Samuelsson, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Physical Review Letters|November 13, 2009
Evidence for two time scales in long SNS junctionsF Chiodi, M Aprili, B Reulet
Drug and Alcohol Dependence|May 1, 1988
Guillain-Barré syndrome in chronic alcoholismL Pastena, F Chiodi, A Ceddia
AIDS Research and Human Retroviruses|August 10, 1996
Conference summary: pathogenic mechanisms of HIV type 1-associated neurological syndromesF Chiodi, S Britton, I Elovaara
Journal of Internal Medicine|June 30, 2007
Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccinesJ Albert, F Chiodi, E M Fenyö
AIDS Research and Human Retroviruses|July 1, 1996
Lack of correlation between V3 amino acid sequence and syncytium-inducing capacity of some HIV type 1 isolatesF Sabri, F Chiodi, E M Fenyö
International Immunology|April 9, 1998
A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sitesB Fadeel, J Lindberg, A Achour, et al.
Virology|August 1, 1991
Brain-derived cells can be infected with HIV isolates derived from both blood and brainB Keys, J Albert, J Kövamees, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1994
Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2E Björling, F Chiodi, G Utter, et al.
Cell Death & Disease|March 18, 2011
Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infectionM Krzyzowska, A Shestakov, K Eriksson, et al.
Chemical Immunology|January 1, 1993
Antigenic and immunogenic sites of HIV-2 glycoproteinsF Chiodi, E Björling, A Samuelsson, et al.
Pageof 10